Achillion Pharmaceuticals, Inc.

Q4 2017 13F Holders

Symbol
ACHN
CUSIP
00448Q201
Type
Equity
Class
COM
Num filings
164
Total reported value, excl. options
$327 M
Manager Report Date Value ($000) Shares Option Type